U.S. stocks on the move: Estée Lauder, PTC, Vaxcyte
PTC•Vaxcyte surged after late-stage pneumococcal vaccine trial success, Estée Lauder rose after Barclays upgraded it to overweight, and PTC surged after Schneider Electric agreed to a $22.6 billion buyout deal.
1. Stocks move on news
Vaxcyte shares surged on late-stage trial success for its pneumococcal vaccine. Estée Lauder rose after Barclays upgraded the stock to overweight, while PTC surged after Schneider Electric agreed to a $22.6 billion buyout deal.
